Meridian Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Meridian Wealth Partners's LLY Position: Q3 2026 in Review
Meridian Wealth Partners reduced its Eli Lilly (LLY) stake by 11% in Q3 2026, selling an estimated $81.4K and leaving 538 shares worth $623K. The position accounts for 0.08% of the portfolio, ranked #57.
Meridian Wealth Partners first reported a position in LLY in Q4 2019 and has held it in 20 quarters since. The position peaked at $728K in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Meridian Wealth Partners held 538 shares of Eli Lilly worth $623K as of Q3 2026.
- Meridian Wealth Partners sold 69 Eli Lilly shares in Q3 2026, an estimated $81.4K.
- Eli Lilly made up 0.08% of Meridian Wealth Partners's portfolio in Q3 2026, its #57 holding.
- Meridian Wealth Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 20 quarters since.
- Meridian Wealth Partners's Eli Lilly position peaked at $728K in Q2 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Meridian Wealth Partners's 13F filing for Q3 2026, filed 9 Nov 2026.